CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.
The panel recently said there was still not enough evidence to properly assess the harms and benefits of such screening.
Influential panel cites lack of evidence of tests’ harms and benefits.
In a new practice guideline, the group also “strongly recommends” that NIPS be offered to patients to screen for fetal SCA.
The new practice guideline also recommends NIPS to screen for fetal sex chromosome aneuploidy.